Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vor Biopharma Inc. Director's Dealing 2021

Feb 9, 2021

33479_dirs_2021-02-09_c0a7485b-4e2e-41e5-91ce-1c0bc9737d17.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2021-02-05

Reporting Person: PARMAR KUSH (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-09 Common Stock C 3308822 Acquired 3308822 Indirect
2021-02-09 Common Stock C 1414026 Acquired 4722848 Indirect
2021-02-09 Common Stock P 111111 $18.00 Acquired 4833959 Indirect
2021-02-09 Common Stock C 1414026 Acquired 1414026 Indirect
2021-02-09 Common Stock P 444444 $18.00 Acquired 1858470 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-05 Stock Option (right to buy) $18.00 A 16900 Acquired 2031-02-04 Common Stock (16900) Direct
2021-02-09 Series A-2 Preferred Stock $ C 45000000 Disposed Common Stock (3308822) Indirect
2021-02-09 Series B Preferred Stock $ C 19230768 Disposed Common Stock (1414026) Indirect
2021-02-09 Series B Preferred Stock $ C 19230768 Disposed Common Stock (1414026) Indirect

Footnotes

F1: Each share of Series A-2 Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock upon the closing of
the Issuer's initial public offering for no additional consideration, on a 13.6 for-one basis, and had no expiration date.

F2: The shares are directly held by 5AM Ventures VI, L.P. 5AM Partners VI, LLC is the general partner of 5AM Ventures VI, L.P. The Reporting
Person is a managing member of 5AM Partners VI, LLC, and may be deemed to share voting and dispositive power over the shares held by 5AM
Ventures VI, L.P. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest
therein.

F3: The shares are directly held by 5AM Opportunities I, L.P. 5AM Opportunities I (GP), LLC is the general partner of 5AM Opportunities I, L.P. The
Reporting Person is a managing member of 5AM Opportunities I (GP), LLC, and may be deemed to share voting and dispositive power over the
shares held by 5AM Opportunities I, L.P. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of
his pecuniary interest therein.

F4: 1/36th of the shares underlying the option vest in equal monthly installments commencing on March 5, 2021, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.